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ABSTRACT
We herein outline the rationale for a Swedish cohort consortium, aiming to facilitate greater use of
Swedish cohorts for world-class research. Coordination of all Swedish prospective population-based
cohorts in a common infrastructure would enable more precise research findings and facilitate
research on rare exposures and outcomes, leading to better utilization of study participants’ data, bet-
ter return of funders’ investments, and higher benefit to patients and populations. We motivate the
proposed infrastructure partly by lessons learned from a pilot study encompassing data from 21
cohorts. We envisage a standing Swedish cohort consortium that would drive development of epi-
demiological research methods and strengthen the Swedish as well as international epidemiological
competence, community, and competitiveness.
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Background
United we stand, divided we fall
At the turn of the millennium, it was recognized that candi-
date gene association studies generated a large amount of
non-replicable results. This rapidly led to a common under-
standing among genetic epidemiologists of the need for
very large sample sizes in order to generate robust results.
These insights seem not to have disseminated consistently
to non-genetic epidemiology. Effectively, the scientific
literature is flooded with underpowered studies, and it is
becoming increasingly recognized that these studies cannot
be replicated, casting doubts on the credibility of research
results in general (1). Hence, there is an urgent need for data
resources where research results can be replicated in an
independent sample. Further, for optimized return on invest-
ment of taxpayers’ and other funders’ money and maximized
benefit to patients and populations, it is essential that
researchers other than those who originally assembled a
database can use and re-use those data (2). These insights
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point, as the way forward, to increasing access to individual
cohorts and leveraging integration of data across studies to
obtain the statistical power required to answer contemporary
research questions.
Why another cohort consortium, and why in Sweden?
The recognition of the need to collaborate has led to develop-
ment of consortia of cohorts in the last decade. Many Swedish
population-based cohorts already participate in a multitude of
international cohort consortia. Some consortia are defined by
access in the participating cohorts to specific exposures (e.g.
the Emerging Risk Factors Collaboration, the International
Database on Ambulatory blood pressure in relation to
Cardiovascular Outcomes, or Research on European Children
and Adults born Preterm) (3–5); others are defined by access to
specific outcomes (e.g. the European Prospective Investigation
into Cancer and Nutrition) (6); while yet others include broad
selections of cohorts with access to very general exposures (e.g.
the NCD Risk Factor Collaboration) (7). Hence, these consortia
are by design limited in terms of inclusion and exclusion criteria
for the participating cohorts and data content.
Sweden is a country with unique opportunities for epi-
demiological research. Together, the governmental agencies
National Board of Health and Welfare (SoS) and Statistics
Sweden (SCB) host a multitude of individual-level data of great
importance for epidemiological researchers (exemplified in
Table 1 and on www.registerforskning.se). Using the 12-digit
personal identity number, unique to all Swedish citizens, infor-
mation from the registers can be uniquely linked (8).
Because most Swedish prospective population-based
cohorts have access to outcomes collected in these registries
in a structured way across the whole nation, Swedish cohorts
have close to complete follow-up for all its participants
except for those who emigrate. All events that are severe
enough to result in e.g. death, an admission or visit to any
hospital (diagnoses classified using the International
Classification of Diseases [ICD] system), a surgical procedure
(classified using the Nordic Medico-Statistical Committee
Classification of Surgical Procedures [NCSP] system), or a
filled drug prescription (classified using the Anatomical
Therapeutic Chemical Classification [ATC] system) are col-
lected in the same way in all cohorts. Hence, a cohort
consortium consisting exclusively of Swedish prospective
population-based cohorts will bring to the table a unique
possibility to study uncommon exposures and outcomes,
classified prospectively.
Other prerequisites for success
The prospective population-based cohort study in a rich offi-
cial registry setting—where a defined, prospectively exam-
ined group of people is followed over time based on a
personal identity number for register linkages—is a highly
valuable observational study design. Sweden has a large
number of carefully collected population-based cohorts that
have been followed for decades. We have ongoing recruit-
ment into several high-quality cohorts. As mentioned, we
have a variety of national socio-demographic and medical
registries, covering the whole population since many deca-
des. In addition, we have a large number of leading epi-
demiological researchers in the country, with a combined
knowledge spanning most current research fields. The
Swedish government has also recently provided strategic tar-
geted funding to epidemiological research.
However, Swedish cohort research is poorly coordinated
today. Many research projects are underpowered by using
only one cohort at a time, leading to uncertain results with lit-
tle benefit to patients and the public. Furthermore, rare dis-
eases and exposures are impossible to study in individual
cohorts due to lack of statistical power and are therefore discri-
minated. Hence, the stage is set for an initiative to unite all
Swedish cohorts in an infrastructure for cohort collaboration.
Pilot study
In order to gain experience from administering a collaborative
cohort project, we undertook a study to identify risk factors for
subarachnoid haemorrhage (SAH) among more than one mil-
lion cohort participants in 21 cohorts (9). SAH was chosen
because it is comparatively rare and most cohorts would be
too small to study this condition. Below, each step is first
described and then commented. Eventually, the study was
completed and presented at a scientific meeting (9). The time
invested in the different processes is illustrated in Figure 1. The
Table 1. Examples of Swedish official registries.
Registry Contents
Swedish Total Population Registry (14) Place of residency; country of own and parents’ birth; marital status; date of
death or emigration
Swedish Censuses Socio-economic group; education; income; sick leave
Swedish National Insurance Agency Sick leave; pensions
Swedish Education Registry Highest education
Swedish 9th Grade Registry Junior high school grades
Swedish Multi-Generation Registry (15) Number of children and siblings; identity of parents if born after 1932 and alive
in 1961
Swedish Medical Birth Registry (since 1973) (16) Numbers of pregnancies and births; pregnancy outcomes
Swedish Prescribed Drug Registry (since 2005) (17) Pharmacy-expedited drug prescriptions
Swedish Inpatient Registry (since 1964, with complete national coverage
since 1987) (18)
Diagnoses of all hospitalizations; surgical and other procedures
Swedish Cancer Registry (since the 1950s) (19) All cancer diagnoses
Swedish Cause-of-Death Registry (20) Causes of death, including contributing factors
Swedish Out-Patient Registries (day-care surgery since 1997, all others
since 2001)
All diagnoses. Hospital-based mandatory; primary care voluntary
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pilot study helped us chart and quantify the multitude of
obstacles involved in cohort research in Sweden in general,
and especially in a collaborative cohort project. The lessons
learned from that project were essential for the development
of the current proposal.
Inclusion of cohorts
The first invitation to participate in the study was sent in
February 2011 to 35 epidemiologists and data managers repre-
senting 29 Swedish cohorts. Because we did not know of all
potential cohorts at the start, additional cohorts were invited
and included until 2014. Ultimately, 21 cohorts participated in
the study. Requirements for cohort data were stated in a
research proposal, with very few inclusion (data on systolic
and diastolic blood pressure and smoking status) and exclu-
sion (previous SAH) criteria. Each cohort had to be enriched
with data from official registries hosted by the National Board
of Health and Welfare (SoS) or Statistics Sweden (SCB). As it
turned out, all but five cohorts were enriched with such data.
Reasons for cohorts declining participation in the project
were of different kinds; most often the cohort holders did not
have the time, or data were deemed unreliable, incomplete, or
unsuitable for the study by the cohort holders. Many cohorts
required applications on their own forms, which was very
time-consuming to comply with. Some cohorts did not have a
steering group or any formal procedures for approval of proj-
ects, which tended to hamper communication.
Ethics approval
The primary application to the ethics review board was sub-
mitted when all cohorts were identified, and cohort holders
had agreed to participate in the project. In the first round of
comments, the ethics review board required details on inclu-
sion criteria for all cohorts, descriptions of the data
extraction procedure from each cohort, details on the infor-
mation given to all participants in each cohort at enrolment
and examples of informed consent forms, and descriptions
of the informed consent procedures in each cohort. After
submission of these complementary documents to the ethics
review board (Figure 2), they found the information to the
Figure 1. Time (h) spent on processes in the pilot study. SAP: statistical analysis plan.
Figure 2. Resubmission to the ethics review board.
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participants about the present study insufficient. The ethics
review board required an advertisement in daily news press,
with instructions on how to opt out of the project. This was
done. The ethics review board approved the study after 6
months of correspondence.
None of the 949,683 cohort participants opted out of
the study. One of the great benefits of cohort studies is
the possibility to study many outcomes, including ones
that were not identified at the time of the design of the
cohort. The ethical and societal gains from that possibility
(the eliminated need for conducting a new cohort study
to answer every new research question) need to be better
recognized and balanced against the limited poten-
tial harms.
Table 2. Proposal for a Swedish Cohort Consortium (Cohorts.se).
Component Description
Data management Some Swedish cohorts are kept at the highest possible standard, with secure storage of data in modern data formats,
including backups, controlled data access, and access logs. Many also have curated data with complete and docu-
mented procedures for data curation as a result of e.g. logical checks, monitoring, adjudication, or outlier detection;
and with data curation traceable through an auditing feature in the data warehouse. Unfortunately, many valuable
cohorts are kept under suboptimal circumstances in some or all of these respects. Sharing experiences and tools for
efficient data management among cohort owners is an important feature of a cohort infrastructure. The Maelstrom
Research offers guidelines (23) and a suite of open source software (24) (Opal, Onyx, Mica, and Agate) to support
management of cohort data. Optimally, all cohorts in the infrastructure would run a local instance of Opal in con-
junction with their other software stack (24). Opal can be used to achieve data management and harmonization. It is
integrated with R, and, using the DataSHIELD approach, such an infrastructure could support advanced statistical
data analysis across cohorts without having to share or disclose individual-level data (11).
Cataloguing Cohort steering groups hold detailed knowledge and documentation on the cohorts’ design, sampling procedures, data
collection methods, losses to follow-up, data quality, and other cumulative knowledge about the data gathered
through a multitude of research projects. Given the complexity in the structure of the existing datasets and the rich
content of the data, the experience of the cohort holders is invaluable for effective use of the data. This experience
needs to be condensed into a useful metadata repository. In Cohorts.se, the Maelstrom approach for study and varia-
bles cataloguing is proposed. A key activity in joint cohort projects is searching for harmonization potential among
cohorts with similar data. A prerequisite for this is a metadata catalogue containing structured details about the
cohort design and the variables and samples collected in the cohort study. In Cohorts.se, it is proposed to use the
Mica software offered by Maelstrom. Mica is a software application for web portals for individual cohorts or for con-
sortia. When used in conjunction with the Maelstrom component Opal, for data management, Mica also allows
authenticated users to perform distributed queries on the content of study databases hosted on remote servers and
retrieve summary statistics (24). A pilot catalogue including 6 studies and 10,000 variables is accessible on www.
maelstrom-research.org/mica/network/cohorts.se
Enrichment In order to stay relevant, epidemiology needs collection of new cohorts, and re-investigation and expansion of existing
cohorts. Cohorts.se proposes to customize and use the Maelstrom’s Onyx software to support high-quality collection
of new cohorts. Onyx is a web-based application that manages participant logistics at cohort assessment clinics,
including appointment management, controlling stage availability and dependencies, consents, questionnaires, sam-
ple collection (barcode scanning), linkage to sensory equipment such as ECGs or scales, producing personalized
reports for participants, and exporting encrypted data to multiple destinations. In addition, Cohorts.se will aid in vari-
able selection for new investigations of cohorts, guided by knowledge of usefulness of existing variable lists in other
cohorts in Cohorts.se. Cohorts.se is also proposed to provide standardized integration of commonly used data sources
like public national registries.
Project management For researchers to conduct projects using the consortium, some information needs to be readily available, including
cohort metadata, variable lists, definitions of variables, and standardized application forms for research proposals. We
propose that Cohorts.se provides basic support for submission of research proposals, coordinates decisions to join a
collaborative project, coordinates data access, provides statistical support as needed, and facilitates critical steps in
the publication process. Further, Cohorts.se should facilitate compliance with legal and ethical requirements, and
ensure complete anonymization of data before delivery to researchers, facilitate meta-analysis or, where relevant, use
federated analysis such as DataSHIELD.
Harmonization In order to make joint analyses, variables from different cohorts need to be measured on the same scale. Using the
Maelstrom approach, harmonization of variables is facilitated and documented in stored scripts (25). Harmonized
data can then be analysed within the Maelstrom system, or exported for analysis on other analysis platforms. The
harmonization process is unique for each research project, but parts will be re-usable in subsequent projects. These
parts will grow over time with shorter and shorter time needed for reprocessing.
Power calculations Cohorts.se should be able to provide data useful for statistical power calculations for all cohorts storing data on an Opal
server connected to Mica. At the moment, user-friendly tools for determining adequate sample size for more com-
plex analyses that include clustered data, family designs, or multiple interactive effects are not readily available.
Power calculations require detailed knowledge about the structure and contents of data in specific cohorts, including
information on missing data for combinations of variables. Assuring that the existing data are adequate for a pro-
posed analysis will likely be a common question.
Statistical analysis Analysing harmonized data from different cohorts today often means transferring and pooling of individual data into a
single large database, but that practice may be infeasible because of time, ethical, or legal issues. DataSHIELD offers
a possibility to analyse data as if they were pooled, though still stored at local Opal servers behind firewalls (11).
Cohorts.se can set up analysis servers at several participating universities, permitting different analyses of the joint
cohort data from multiple access points.
Local cohort operations The backbone of Cohorts.se is the participating cohorts and all persons involved in the management of the cohorts. For
a successful infrastructure, incentives must be developed for the cohort holders to keep their cohorts safely stored in
modern formats on adequate hardware, accessible for research projects, up to date in the Cohorts.se catalogue, suffi-
ciently staffed with data management personnel, and governed by a functioning steering committee or other body.
Within Cohorts.se, a charter with recommendations of levels of governance, maintenance, data storage, and data cur-
ation will be proposed.
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Data processing agreements
Personal data cannot legally be transferred between entities
without a written agreement between the data controller
(the sending part) and the data processor (the receiving
part). Such agreements were set up between each cohort
and Uppsala Clinical Research Center (UCR). It is the responsi-
bility of the data controller to set up such agreements, but
UCR did this as an extra service.
Many cohort representatives were entirely unfamiliar with
the legal requirements. In some cases, UCR had not received
copies of the signed agreements from the cohort representa-
tives after two reminders, although UCR had signed them
and received the data. In some cases, the cohorts had devel-
oped their own data transfer agreement forms, with
unknown relationships to the legal data controlling entity
(typically a university).
Data transfer
The project used the UCR data transfer system, which com-
plies with Swedish and EU data security laws (21, 22), and
ensures that data are handled to the highest possible stand-
ard, with access restrictions and data encryption in transit
and at rest. Contact between data managers for each cohort
and the data manager at UCR was essential for secure data
transfer in accordance with UCR standard operating proce-
dures. In some cases, no cohort data manager was available,
and the cohort holder or a research assistant made the
data transfer.
It is of high importance to identify the data manager early
in the process for most effective communication. One
researcher sent the data using Hotmail, which led to a notifi-
cation by the Quality Assurance team at UCR. A federated
system such as DataSHIELD (11) without the need to physic-
ally send data would better safeguard participants’ integrity.
Enrichment with registry data
Five of the 21 cohorts were not enriched with data from SCB
and SoS at the time of the invitation to the study. For these
five cohorts, the UCR project manager applied for selected
variables from SoS and SCB. An application was written to
SoS, and the same form was used for the application to SCB.
The ethical approval together with a protocol synopsis were
attached as well as a list of needed variables. The five cohort
datasets were sent with personal identification numbers to
SoS. SoS delivered the enriched datasets to SCB. SCB
enriched the datasets further and sent them pseudonymized
(without personal identification numbers) to the research
group at UCR. This procedure was very time-consuming. One
reason was that SoS and SCB appeared to have no direct
communication between each other.
A federated system such as DataSHIELD (11) (and the sys-
tem proposed in an accompanying article in this issue of the
Journal) with participation of SoS and SCB, would be prefer-
able for optimizing speed and integrity.
Data harmonization
The final database required harmonization of a dozen varia-
bles. This harmonization is a crucial step in a project where
the aim is to analyse pooled data. The harmonization work
(processing study-specific data under a common format) was
performed at UCR, and took a very long time for several rea-
sons besides the difficulties related to data management and
processing. The documentation for many of the variables
(data dictionaries) was incomplete, or even non-existent, for
many of the cohorts. The relevant staff at the cohorts was
not always identified at the start, and finding the right per-
son could be cumbersome. Even when the right person was
identified, responses by mail or telephone were sometimes
very slow. Preliminary results were presented to the cohort
holders and data managers at a teleconference meeting.
Misunderstandings of the research proposal were sorted out.
Solving those issues was quite swift, and the database was
considered final soon after the meeting.
Using dedicated tools such as Maelstrom (23) for data
descriptions and dictionaries and for harmonization is likely
to considerably speed up the process. Presenting descriptive
analyses at a teleconference at an early stage is also likely to
speed up harmonization—inspection of variable distributions
stratified by cohorts gives opportunities for cohort represen-
tatives to identify mistakes or misunderstandings.
Statistical analysis
A statistical analysis plan was presented in 2014, specifying
that associations of risk factors with SAH should be analysed
using Cox proportional hazards models, accounting for the
clustered data structure using shared frailty models. During
the analysis work, we decided to change to Poisson models
instead. Reasons for this were that two time scales were of
interest (calendar time and age) and that cohorts collected
decades apart were difficult to model using Cox regression.
Other peculiarities in the data observed at the time of ana-
lysis were that not all ages were present in all calendar peri-
ods; and problems with correctly identifying events and
event-free time because registries used to capture the out-
come did not cover all of Sweden until 1987, and because
some cohorts with very long follow-up needed to account
for several ICD code versions and had not done so initially.
It is a good idea to study descriptive statistics for each
cohort in parallel with statistical analysis plan development
and share those data with the cohorts, both in order to
check harmonization of key variables and to make sure that
the plan fits the data. Principles for missing data imputation
should be determined at the outset, but may need to be
refined once data are in. Good communication between prin-
cipal investigator/statistician/data manager is important.
Proposal
We have led an initiative for a national collaborative infrastruc-
ture, the Swedish Cohort Consortium (Cohorts.se). The full proposal
can be found on www.cohorts.se, with contributing cohorts and
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researchers listed on https://snd.gu.se/sv/catalogue/keyword/
cohortsse; Table 2 provides a condensed outline.
The long-term scientific goal is to facilitate greater use of
Swedish cohorts for world-leading research; excellence would
mainly be achieved by making cohort data discoverable and
more accessible and supporting collaborations between cohorts.
Important components of such an infrastructure would
build on open access and open science and involve data cur-
ation and management, cataloguing study designs and varia-
bles content, developing common procedures for access to
data, harmonizing variables to support research projects,
linking cohorts and official registries using novel techniques,
achieving statistical analysis including a method for distrib-
uted data analysis eliminating the need to send data
between cohorts, and implementing collaborative web
interfaces for researchers, data managers, statisticians, and
publication managers.
The proposed undertaking is not trivial. Even with appro-
priate approaches such as these, the terminologies, proce-
dures, technologies, and methods used vary markedly
between cohorts. Because of this complexity and the hetero-
geneity of information collected from pre-existing cohorts,
integration of the information presents major challenges.
Achieving scientifically valid harmonization requires secure
data environments and specialized expertise and resources.
Our initiative aims to fill this need.
Ethical considerations
Ethical, legal, and social implications of collaborative cohort
analysis arise from the fact that cohorts are initiated with dif-
ferent goals, and that participants in different cohorts there-
fore will have been given different information about the
intended use of the data. The consent procedures may vary
widely across cohorts. Permission from an ethics review board
is a valid proxy for consent from the cohort participants when
applied to secondary analyses of the data (10), and handling of
all collaborative projects in the infrastructure at an ethics
review board experienced in such research, such as the pro-
cedure in the UK Biobank, would be a great advantage.
Other ethical issues may result from an increased accessi-
bility of the cohorts to the research community, including
risks of breaches of security and privacy. Cohorts.se aims to
develop appropriate means of data access that ensure priv-
acy and secure data handling. In order to protect the privacy
of individuals, but at the same time utilize the strength that
some individuals participate in multiple cohorts, a novel
secure technique has been proposed for joining cohorts
using the personal identity number (see accompanying
paper by Sn€ackerstr€om and Johansen in this issue of the
Journal). Use of DataSHIELD (11) also minimizes the risk.
The main ethical gains from facilitating collaborative
cohort analysis include benefits to patients and populations
in the form of more precise, timely, and reliable research
findings due to better-powered studies, and research find-
ings that would be impossible to obtain without collabora-
tive analysis. Ethical gains from increasing the accessibility to
and use of cohort data are that study participants’ data are
better utilized and their donation therefore becomes more
valuable, with higher benefit to patients and populations.
Other ethical advantages may include safer management
of sensitive person data and higher equality in access to
necessary support functions. Today, the management of
some cohorts is very vulnerable, with insecure backup rou-
tines and key knowledge about the cohort maintained by
single persons. In Cohorts.se, data management will be sig-
nificantly improved compared to the standards in place at
the weakest environments today. We propose common data
and material transfer agreements for all cohorts, saving time
and ensuring that all cohorts are treated equally. We also
propose transparent and clearly stated common rules for
liabilities, access rights, and limits of use based on inter-
national charters for sharing and access to data.
Potential gains to society
Less waste in research
Cohorts.se will facilitate modern data curation and manage-
ment, which will allow us to increase the level of data secur-
ity, ensuring future-proof storage of valuable Swedish
cohorts. There is a clear threat of total oblivion for older
cohorts with low to minimal use and vulnerable manage-
ment structures. Cohorts.se will catalogue all cohorts in a
detailed and structured way, which will facilitate use of valu-
able cohort data that are known only to a smaller circle of
researchers today and therefore under-used. A pilot cata-
logue including six studies and 10,000 variables is accessible
on www.maelstrom-research.org/mica/network/cohorts.se.
Table 3. International infrastructures with which collaboration may be sought.
Name Website
The Asia-Pacific Cohort Studies Collaboration www.apcsc.net
Emerging Risk Factors Collaboration www.phpc.cam.ac.uk/ceu/research/erfc
Prospective Studies Collaboration www.ctsu.ox.ac.uk/research/meta-studies/psc/psc-website
Monica Risk, Genetics, Archiving and Monograph (MORGAM) www.thl.fi/morgam
Biomarker for Cardiovascular Risk Assessment in Europe (BiomarCaRE) www.biomarcare.eu
National Cancer Institute (NCI) Cohort Consortium http://epi.grants.cancer.gov/Consortia/cohort.html
European Cohort Consortium (follow-up to BBMRI-LPC) www.bbmri-lpc.org
Research on European Children and Adults born Preterm (RECAP) https://recap-preterm.eu/
The Maelstrom software suite (23) is used for several of these collaborations, including the NCI Cohort Consortium, BBMRI-LPC, and RECAP.
Using the same suite of tools for Cohorts.se will facilitate collaboration with those international consortia. Some Swedish cohorts are already
catalogued in Maelstrom, including ULSAM, EpiHealth, LifeGene and TwinGene. The continuation of the BBMRI-LPC is uncertain, but there are
initiatives to transform it into a European Cohort Consortium, which will most likely be open for inclusion of more Swedish cohorts. Some of
the other networks that use Maelstrom are described on https://www.maelstrom-research.org.
26 J. SUNDSTR€OM ET AL.
Cohorts.se will reduce the time wasted waiting for results.
As an example, the 14,000,000 person-years of follow-up in
the pilot study of this infrastructure (9) would take UK
Biobank (500,000 screened subjects) 28 years to acquire. This
means that Cohorts.se will allow world-leading research that
may be impossible to achieve elsewhere today.
A common infrastructure for all cohorts can facilitate access
to data about the cohort participants held by Statistics
Sweden and the National Board of Health and Welfare, and
potentially reduce the very long (currently up to 2 years) wait-
ing times for data at these governmental agencies.
Combining multiple cohorts permits better-powered solutions
for any research question that is today explored in single cohorts,
generating more precise results. But it is especially valuable as it
permits timely and adequately powered research on rare dis-
eases, rare exposures, and extreme levels of exposures.
Building competence, community, and competitiveness
Cohorts.se will provide collaborative interfaces for researchers,
data managers, and biostatisticians, including national meet-
ings and educational efforts. We have good reason to believe
that this will drive development of epidemiological research
methods, increase the quality of research projects, maximize
the prospects of getting research projects funded by inter-
national funding agencies, and in the long run secure excel-
lent research environments and influx and retention of
excellent researchers. This has been the case in Norway,
where a structured collaboration between cohorts over two
decades has played an important role in developing epi-
demiological research environments and projects and facili-
tating cohort collaborations (12). Further support for the
forecast that a cohort collaboration infrastructure will drive
research excellence comes from the Emerging Risk Factors
Collaboration. This task has led to a very strong development
of cohort research methods, the legacy of which includes
important publications in leading medical journals, a large
suite of statistical software developments, shared freely on
their website (13), as well as personal experience, compe-
tence, and networks among the leading researchers.
This proposal has been developed at two national work-
shops among cohort researchers taking part in the pilot
study of Cohorts.se, and subsequently in writing groups com-
posed of researchers from all parts of Sweden. Participants in
these activities have reported the networking with new
acquaintances with similar interests as very fruitful. The
popularity of this proposal is also reflected in the fact that
since the initiation of the pilot study the number of cohorts
in the initiative has more than doubled, with a total of more
than 40 cohorts at seven universities participating in the pro-
posal. Cohorts.se aims to eventually embrace all interested
prospective population-based Swedish cohorts.
The long-term strategic importance of Cohorts.se for the
Swedish medical research community is great. It will add
lasting value to existing cohorts, registries, and researcher
groups, providing an opportunity for Sweden to obtain a
leading position in epidemiology and further attract leading
international researchers. It can facilitate Swedish
participation and leadership in international cohort collabora-
tions, such as those in Table 3. The importance to the
pharmaceutical industry of uncovering the pathophysiology
of uncommon diseases may also be vital.
Conclusion
In sum, coordination of all Swedish prospective population-
based cohorts in a common infrastructure would enable
more precise research findings and facilitate research on rare
exposures and outcomes, leading to better utilization of
study participants’ data, better return of funders’ invest-
ments, and greater benefit to patients and populations. We
envisage a strong standing Swedish cohort consortium that
would drive development of epidemiological research meth-
ods, and strengthen the Swedish epidemiological compe-
tence, community, and competitiveness.
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